Manila Times Business
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
All resolutions recommended by the Board of Directors approved (quorum: 32.13 %)Lille (France); Cambridge, (Massachusetts, United States); Zurich (Switzerland); June 15, 2026 - GENFIT (Euronext: GNFT),, a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the results of the Combined Shareholders Meeting which took place on June 15, 2026. The quorum on first convening amounted to 32.13 % and shareholders approved a
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Football: World Cup results
Just now
Xenkrupom Unveils Its Next-Generation AI Trading Platform, Redefining Intelligent Investing in 2026
Just now
CoreGLP Avis [DE, AT, CH, FR, BE, DK, FI, SE, NL] - The Truth Behind the Wellness Supplement Generating Buzz in 2026
Just now
Immigration agent fires gun after being hit by vehicle in New Jersey, police say
Just now